13-77057078-T-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_015057.5(MYCBP2):āc.13345A>Cā(p.Ile4449Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,612,786 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/17 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_015057.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYCBP2 | NM_015057.5 | c.13345A>C | p.Ile4449Leu | missense_variant | Exon 79 of 83 | ENST00000544440.7 | NP_055872.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYCBP2 | ENST00000544440.7 | c.13345A>C | p.Ile4449Leu | missense_variant | Exon 79 of 83 | 1 | NM_015057.5 | ENSP00000444596.2 | ||
ENSG00000283208 | ENST00000638147.2 | c.566-18440T>G | intron_variant | Intron 3 of 4 | 5 | ENSP00000490953.2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152220Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250286Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135478
GnomAD4 exome AF: 0.00000959 AC: 14AN: 1460448Hom.: 0 Cov.: 29 AF XY: 0.0000110 AC XY: 8AN XY: 726634
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152338Hom.: 0 Cov.: 32 AF XY: 0.0000268 AC XY: 2AN XY: 74504
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.13345A>C (p.I4449L) alteration is located in exon 79 (coding exon 79) of the MYCBP2 gene. This alteration results from a A to C substitution at nucleotide position 13345, causing the isoleucine (I) at amino acid position 4449 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at